Searchable abstracts of presentations at key conferences in endocrinology

ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Endocrine Abstracts

Published by BioScientifica

Previous issue | Volume 14 | ECE2007 | Next issue

9th European Congress of Endocrinology

Poster Presentations

(1)

Table of contents

Human adrenal NCI-H295R cells produce more C19 steroids than NCI-H295A cells – a possible model to study regulation of androgen biosynthesis?

Effects of ethanol and blokade of synthesis of nitric oxide on level of ACTH in female rats

Study of the hypothalamic-pituitary-adrenal axis in patients with the antiphospholipid syndrome

Survey of thyroid function of Hungarian Vizsla population in Hungary

Pancreatic polypeptide (PP) radioimmunoassay in acute phase and regression of cerulein induced pancreatitis

Evaluation of neuroendocrine disfunction in hypothalamo-pituitary-adrenal axis in diagnosis of depressive and non-depressive alcohol-dependent persons

Effects of melatonin on glutathione peroxidase activity after adriamycin in normal and pinealectomized rats

Is there any role for anti-inflammatory cytokine Interleukin-10 in advanced congestive heart failure?

Regulation of GAGEC1, a cancer-testis associated antigen family member, by sex steroid hormones and TGF-beta: implications for prostatic disease

ea0014p10 | (1)

Normalization of serum testosterone level alters local GnRH-II and IL-2R mRNA expression in peripheral lymphocytes in patients with idiopathic hypogonadotrophic hypogonadism (IHH)

ea0014p11 | (1)

Blocking undesired leptin action in vivo with leptin antagonists prepared by site-directed mutagenesis of human, ovine, rat and mouse leptin site III

ea0014p12 | (1)

Role of soluble Fas-antigen (sFas), interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) in adrenocortical carcinoma patients

ea0014p13 | (1)

Rosiglitazone interferes with the inflammatory response induced in human endothelial cells by TNFalpha and IFNgamma through a new mechanism involving extracellular signal-regulated kinases (ERKs)

ea0014p14 | (1)

Role of growth hormone/insulin like growth factor 1 system in the remodelling process of the right ventricle in top levels rowers

ea0014p15 | (1)

Clinical significance of simultaneously determined serum interleukin-6, dehydroepiandrosterone and its sulphate levels in melanoma

ea0014p16 | (1)

Changes in growth hormone messenger RNA (GHmRNA) expression in rats anterior pituitary after single Interferon (IFN)alpha administration.

ea0014p17 | (1)

Does stress test influence Interleukin (IL)-2 and IL-8 concentration in serum patients with stable ischaemic heart disease?

ea0014p18 | (1)

Concentration of inflammatory factors such as CRP (acute phase response protein) and Interleukin (IL)-6 in serum patients with stable ischemic heart disease during trimetazidine treatment

ea0014p19 | (1)

Insulin decreases IGF-I bioactivity in patients with impaired glucose tolerance and in healthy subjects

ea0014p20 | (1)

Plasma free fatty acids and adipocytokines concentration in relation to insulin sensitivity in patients with anorexia nervosa.

ea0014p21 | (1)

Improved glucose metabolism and altered pancreatic structure in transgenic mice overexpressing betacellulin

ea0014p22 | (1)

Screening of 120 adipokines in subcutaneous adipose tissue of patients with growth hormone deficiency reveals changed protein levels

ea0014p23 | (1)

Human somatotrophic (GH) adenoma cells – interleukin (IL)-1β induces production of il-6 and il-8.

ea0014p24 | (1)

Serum ferritin concentrations in an impaired fasting glucose population and their normal control group

ea0014p25 | (1)

Implications of serum resistin in overweight diabetic patients with ischemic heart disease

ea0014p26 | (1)

The protective effect of tribulus terrestris in diabetes

ea0014p27 | (1)

Prevalence of I27L polymorphism of hepatic nuclear factor-1[alpha] in diabetic patients younger than 35 years old.

ea0014p28 | (1)

Novel mechanism of chronic exposure of oleic acid-induced insulin release impairment in rat pancreatic β-cells

ea0014p29 | (1)

Quality of care in a diabetic outpatient clinic

ea0014p30 | (1)

Cardiovascular risk factors (CVRF) as predictors of microalbuminuria (MA) in type 2 diabetes mellitus (T2DM) patients

ea0014p31 | (1)

The prevalence of metabolic syndrome and its relation to metabolic control in patients with diagnosed type 2 diabetes

ea0014p32 | (1)

Effects of rosiglitazone (RGZ) and pioglitazone (PGZ) on serum androgens and urinary steroid profile in patients with type 2 diabetes: A prospective, randomised cross-over study

ea0014p33 | (1)

Abnormal glucose challenge test reflects mild gestational diabetes

ea0014p34 | (1)

Ambulatory blood pressure reduction after rosiglitazone treatment in normotensive type 2 diabetic patients

ea0014p35 | (1)

Time dependent effects of rosiglitazone on heart and fluid dynamics: a 6-month follow up study

ea0014p36 | (1)

Peculiarities of heart rate control in patients with non-insulin dependent diabetes mellitus and hypertension

ea0014p37 | (1)

One injection of Detemir insulin administered before the lunch improves the metabolic control in type 1 diabetic patients

ea0014p38 | (1)

Oral antibodies to insulin receptor are found effective in the treatment of streptozotocin-induced diabetes in rats

ea0014p39 | (1)

1 year endurance training at the level of the ventilatory threshold in type-2 diabetics reduces by 50% healh costs: a controlled randomized trial

ea0014p40 | (1)

PED levels are increased in peripheral blood leucocytes from euglycaemic subjects at-risk of type 2 diabetes

ea0014p41 | (1)

Effectiveness of α-lipoic acid in prevention of peripheral diabetic neuropathy

ea0014p42 | (1)

Adhesion molecules s-VCAM-1 and s-ICAM-1 in members of families with familial combined hyperlipidemia

ea0014p43 | (1)

Body fat distribution, lipid and adipokine levels in South African type 2 diabetic patients of African and Indian origin

ea0014p44 | (1)

Low dose cyclosporin and methotrexate administration induces remission of Type 1 diabetes mellitus

ea0014p45 | (1)

Progression of diabetic retinopathy in pregestational diabetes mellitus

ea0014p46 | (1)

Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acorbose in type 2 diabetes

ea0014p47 | (1)

Competition between catecholamines and glucose for binding sites on proteins of erythrocytes

ea0014p48 | (1)

Body composition, emotional state and quality of life in patients with diabetes mellitus type 2

ea0014p49 | (1)

Deleterious effects of beta-blockers on arterial stiffness and central pulse pressure in menopausal women: baseline findings from the Cashmere trial

ea0014p50 | (1)

Prevalence of GADA and IAA in elderly patients with type 2 diabetes

ea0014p51 | (1)

Comparison of plasma homocysteine concentrations (HYC) in patients with acute coronary syndrome (ACS) and newly or previously diagnosed type 2 diabetes

ea0014p52 | (1)

The association between carotid artery intima-media thickness and cardiovascular mortality and morbidity in Type 2 diabetes: a retrospective study

ea0014p53 | (1)

Comparison of the effects of gliclazide and glibenclamide on insulin resistance and metabolic parameters

ea0014p54 | (1)

24-hour ambulatory blood pressure and aortic dimensions in women with Turner syndrome

ea0014p55 | (1)

Plasma marker of lipid peroxidation and type 2 diabetes in subject with coronary artery disease in Iranian subjects

ea0014p57 | (1)

Effect of testosterone replacement therapy on adipocytokines in hypogonadal men with Type 2 diabetes

ea0014p57 (1) | (1)

Effect of testosterone replacement therapy on adipocytokines in hypogonadal men with Type 2 diabetes

ea0014p58 | (1)

A role of the liver in the infringements of lipid metabolism of patients with diabetes mellitus type 2 and metabolic syndrome

ea0014p59 | (1)

Radionuclide study of hepatobiliary system function in patients with type 2 diabetes and metabolic syndrome

ea0014p60 | (1)

Omega-3 polyunsaturated fatty acids in the treatment of cardiovascular autonomic neuropathy in Type 2 diabetes mellitus patients

ea0014p61 | (1)

Nicotinamide and alpha-lipoic acid in the treatment of cardiovascular autonomic neuropathy in Type 2 diabetic patients

ea0014p62 | (1)

Plasma measures of oxidative stress and antioxidant status in type 2 diabetes mellitus

ea0014p63 | (1)

Does screening of primary hyperaldosteronism only lead to diagnosis of more adrenal hyperplasia?

ea0014p64 | (1)

Liquorice in moderate doses decreases serum levels of vitamin B12 but does not affect the serum lipid levels

ea0014p65 | (1)

Decreased insulin sensitivity in young lean hypertensive men is not associated with increased visceral fat and changes in plasma adipocytokines

ea0014p66 | (1)

Comparison of twice daily NPH insulin versus once daily glargine insulin in the frequency of nocturnal hypoglycemia in Type2 diabetic patients with congestive heart failure

ea0014p67 | (1)

Intravenous constant ghrelin infusion in healthy young men: sustained cardiovascular effects of supraphysiological ghrelin levels

ea0014p68 | (1)

Circulating retinol binding protein 4 and protein C inhibitor are not related to insulin resistance

ea0014p69 | (1)

KCNJ11 and ABCC8 promotor variants in congenital hyperinsulinism

ea0014p70 | (1)

Effect of L- carnitine supplementation on glycemic profile in patients with type 2 diabetes mellitus

ea0014p71 | (1)

Raised serum, adipocyte and adipose tissue retinol binding protein 4 (RBP4) in women with polycystic ovary syndrome

ea0014p72 | (1)

Polymorphisms of von Willebrand factor gene promoter modulate the corticosteroid-mediated increase of VWF levels in Cushing’s syndrome.

ea0014p73 | (1)

Circulating pro- and anti-inflammatory cytokines in women with gestational diabetes

ea0014p75 | (1)

Metabolic improvement in diabetic patients with glucose continuous monitoritation in real time

ea0014p76 | (1)

The role of stress related aldosterone secretion in essential hypertension

ea0014p77 | (1)

Dialysis therapy and its complications

ea0014p78 | (1)

The effect of interferon treatment on glucose metabolism in patients with chronic hepatitis

ea0014p79 | (1)

Unacylated ghrelin (UAG) enhances the early insulin response to meal, improves glucose metabolism and decreases free fatty acids levels in healthy volunteers

ea0014p80 | (1)

Weight-related concentrations of steroid hormones in patients of both sexes with preserved gonadal function suffering from coronary artery disease

ea0014p81 | (1)

Diabetic patient’s evaluation of continuous glucose monitoring sensors versus capillary glucose measurements

ea0014p82 | (1)

Dehydroepiandrosterone therapy in men with verified coronary heart disease: the effects on fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA)

ea0014p83 | (1)

Insulin resistance and insulin secretion in non-diabetic acromegalic patients

ea0014p84 | (1)

Response to metformin treatment in adolescent siblings with familial partial lipodystrophy of the dunnigan variety (FPLD) due to the R482W LMNA gene mutation

ea0014p85 | (1)

Insulin sensitivity and lipid levels in pateints with primary hyperparathyroidism

ea0014p86 | (1)

The effect of surgical treatment on insulin sensitivity in pateints with primary hyperparathyroidism

ea0014p87 | (1)

Insulin-sensitivity and glycaemic control improve on rosuvastatin (RSV) treatment in hypertriglyceridaemic type-2 diabetes (T2DM)

ea0014p88 | (1)

Gestational diabetes mellitus and adiponectin levels

ea0014p89 | (1)

Lipoprotein Lp(a) in patients with systemic lupus erythematosus. Relationship with disease activity and anticardiolipin antibodies

ea0014p90 | (1)

Lipoprotein Lp(a) in patients with rheumatoid arthritis and its relationship with disease activity

ea0014p91 | (1)

Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients, who display fat redistribution

ea0014p92 | (1)

Concentration of vasopressin and of N- terminated naturetic propeptyde type B – potent predictors of survival of patients after cardiac arrest

ea0014p93 | (1)

Changes in plasma adiponectin during the treatment of diabetic ketoacidosis

ea0014p94 | (1)

Power spectral analysis (PSA) of heart rate variability (HRV) in the detection of cardiac autonomic neuropathy (CAN) in subjects with diabetes mellitus

ea0014p95 | (1)

Glicoregulation in obese diabetics treated with glargin insulin in combination with metformin and with glargin in combination with glimepirid

ea0014p96 | (1)

High-sensitivity C-reactive protein in diabetes mellitus type II according to micral test findings

ea0014p97 | (1)

Localization of an ectopic adrenocorticotropin-secreting tumour using ¹⁸F- Dopa PET/CT

ea0014p98 | (1)

Adrenocortical carcinosarcoma: first european case report

ea0014p99 | (1)

The genetic association of medullary thyroid carcinoma with Hirschsprung’s disease

ea0014p100 | (1)

Inhibition of C_17,20-lyase activity by new 17β-exo-heterocyclic androsterone derivatives

ea0014p101 | (1)

Cigarette smoking increases high calcitonin levels

ea0014p102 | (1)

Cortisol excess, inflammatory markers and echocardiographic alterations in adrenal incidentalomas

ea0014p103 | (1)

Prognostic value of anti-thyroperoxidase antibodies in high malignancy degree breast cancer

ea0014p104 | (1)

Bone density in patients with non-functioning pituitary adenomas (NFA)

ea0014p105 | (1)

Echo-enhanced ultrasound has a higher sensitivity than high-resolution CT in the detection of hepatic metastasis of adrenocortical carcinoma

ea0014p106 | (1)

Characteristics of metabolic syndrome in patients with adrenal incidentaloma

ea0014p107 | (1)

The role of radio-guided surgery (RGS) with the use of ^99mTc-EDDA/HYNIC-octreotate in detection of unknown primary and secondary sites of neuroendocrine tumours of the gastrointestinal tract (GEP-NET) and improving the final outcome of patients

ea0014p108 | (1)

Ascl1 is abundantly expressed in endocrine pancreatic tumors

ea0014p109 | (1)

Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia?

ea0014p110 | (1)

Thyroid cancer and pregnancy: clinical outcome and time of diagnosis in a series of 94 women

ea0014p111 | (1)

RET genotypes comprising specific haplotypes of polymorphic variants are associated with sporadic medullary thyroid cancer

ea0014p112 | (1)

Isolation of the Side population (SP) from murine adrenal glands renders cells with adrenocortical stem cell properties

ea0014p113 | (1)

Selective intra-arterial calcium stimulation with hepatic venous sampling in investigation of hyperinsulinemic hypoglycemia

ea0014p114 | (1)

Somatostatin and dopamine receptor regulation and effects of a new somatostatin/dopamine chimeric compound on cell proliferation of the human androgen-dependent prostate cancer cell line LNCaP

ea0014p115 | (1)

Somatostatin receptor regulation and effects of somatostatin and somatostatin analogues on cell proliferation of the human androgen-dependent prostate cancer cell line LNCaP

ea0014p116 | (1)

Conjugated and unconjugated serum steroid hormone concentrations in relation to tumour receptor status in postmenopausal breast cancer patients

ea0014p117 | (1)

A novel activating germline mutation in the RET gene (Y606C) in a patient with medullary thyroid carcinoma

ea0014p118 | (1)

Novel germline VHL mutations associated to uncommon clinical presentations

ea0014p119 | (1)

The expression of alternatively spliced forms of type 1 deiodinase is changed in clear cell renal cell carcinoma

ea0014p120 | (1)

Ret expression reduces estrogen-induced lactotrope hyperplasia

ea0014p121 | (1)

Analysis of BRAF point mutation in papillary thyroid carcinoma

ea0014p122 | (1)

Effect of surgery on carotid vascular remodeling in patients with pheochromocytoma

ea0014p123 | (1)

A case report of ectopic Cushing’s disease presented with trombocytopenia

ea0014p124 | (1)

Influence of Lanreotide Autogel on insulin sensitivity among patients with acromegaly

ea0014p125 | (1)

A newly detected mutation of the RET proto-oncogene in exon 8 as a cause of multiple endocrine neoplasia Type 2A

ea0014p126 | (1)

Clinical and biochemical effects of adjuvant mitotane treatment in patients with adrenocortical cancer (ACC)

ea0014p127 | (1)

Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake

ea0014p128 | (1)

Expression of the neuropeptide cortistatin in haematological malignancies

ea0014p129 | (1)

A loss-of-function polymorphic mutation in the P2X7 receptor gene in patients with papillary thyroid cancer

ea0014p130 | (1)

Enhanced expression of functional P2X₇ receptor in human papillary thyroid cancer

ea0014p131 | (1)

Results 90Y-DOTATATE therapy in patients with neuroendocrine tumours (NETs) - own experience

ea0014p132 | (1)

Results of treatment of patients with pituitary somatotroph adenomas

ea0014p133 | (1)

Adrenal incidentaloma, an oncological or endocrinological enigma? Clinical analysis of 1300 cases observed at a single endocrinological centre

ea0014p134 | (1)

Frequency and type of adrenal tumors in our patients

ea0014p135 | (1)

Papillary thyroid cancer – the possible role of death ligands in tumor immunology

ea0014p136 | (1)

Leptin and adiponectin interact in regulating prostate cancer cell growth

ea0014p137 | (1)

A novel role for Visfatin/Pre-B cell colony-enhancing factor 1 (PBEF)/Nicotinamide phosphoribosyltransferase (NMPRTase) in prostate carcinogenesis

ea0014p138 | (1)

Initial presentation of patients with acromegaly - analysis of the German acromegaly register

ea0014p139 | (1)

Survivin – a promising target for immunotherapy in patients with adrenocortical carcinoma

ea0014p140 | (1)

Thyroid cancer: with an unexpected location – in the pancreas and in an unexpected combination with Boeck’s sarcoidosis

ea0014p141 | (1)

Thyroglobulin-antibodies in the “normal” range may decrease the diagnostic accuracy of thyroglobulin in the care of patients with differentiated thyroid cancer

ea0014p142 | (1)

Dopamine receptor expression and dopamine agonist effectiveness in post-surgical persistent medullary thyroid cancer

ea0014p143 | (1)

Somatostatin analogues and the PI3K-AKT-MTOR-P70S6K pathway: how do they control the proliferation of neuroendocrine tumours?

ea0014p144 | (1)

Angiotensin 4–8 and angiotensin 5–8 inhibit cell proliferation in GH3 rat pituitary lactosomatotroph tumor cell culture

ea0014p145 | (1)

Epidermal growth factor receptor (EGFR) as a potential new target in the treatment of patients with adrenocortical carcinoma – results of pre-clinical studies

ea0014p146 | (1)

Time necessary to achieve the maximum effect of goserelin, LH-RH agonist, in therapy of hormone dependent breast cancer

ea0014p147 | (1)

Acromegaly due to a lung carcinoid: a case report

ea0014p148 | (1)

Intra- and supra-sellar immature teratoma mimicking pediatric craniopharyngioma

ea0014p149 | (1)

Pituitary microprocess

ea0014p150 | (1)

Adrenal incidentalomas and insulin sensitivity – are there any differences between adenomas and hyperplasia?

ea0014p151 | (1)

Frequency of occurence of MEN1 syndrome in patients admitted with primary hyperthyroidism

ea0014p152 | (1)

Evaluation of the efficacy of sandostatin LAR in the treatment of acromegaly

ea0014p153 | (1)

The beta-HLH transcription factor neurogenin-2 is preferentially expressed by secreting pituitary adenomas

ea0014p154 | (1)

TGFß1 signalling in human insulinomas compared with human islets.

ea0014p155 | (1)

The effect of SOM230 on cell proliferation and cortisol secretion in the human adrenal carcinoma cell line H295R

ea0014p156 | (1)

MEN2B – Two simultaneous cases of a rare syndrome

ea0014p157 | (1)

Prevalence of autonomous cortisol and aldosterone secretion in patients with a single benign cortical adrenal adenoma after modification of the diagnostic tests

ea0014p158 | (1)

Immunohistochemical detection of angiotensin receptors AT1 and AT2 in adrenal tumors

ea0014p159 | (1)

Bilateral adrenal incidentalomas: exploration of aberrant responses and comparison with unilateral lesions

ea0014p160 | (1)

Inhibitory effect of rosiglitazone – PPARgamma receptor ligand on growth of human adrenocortical tumor cells in vitro

ea0014p161 | (1)

The modern pre- and intraoperative diagnostic algorithm of pancreatic NET with the use of 99mTc-EDDA/HYNIC-octreate scintigraphy – the impact of SRS on patients’ management

ea0014p162 | (1)

Segregation of P25L and S80I mutations of the vhl gene in an extended Hungarian family with von Hippel-Lindau syndrome

ea0014p163 | (1)

High prevalence of novel mutations of the MEN1 gene in Hungarian patients with multiple endocrine neoplasia type 1

ea0014p164 | (1)

Analysis of germline mutations in patients with pheochromocytomas and paragangliomas

ea0014p165 | (1)

RET exon 13 germline polymorphism in patients with pheochromocytomas and paragangliomas

ea0014p166 | (1)

Cabergoline suppression test in distinguishing the variability of response to dopamine agonists in prolactinomas

ea0014p167 | (1)

Predictive value of pituitary histology on clinical outcome in acromegaly: a retrospective cohort study

ea0014p168 | (1)

Somatostatin receptor immunohistochemistry in neuroendocrine tumors: a proposal of scoring system for clinical characterization and therapy selection

ea0014p169 | (1)

Prevalence of primary aldosteronism among hypertensive patients (preliminary results)

ea0014p170 | (1)

Leptin modulates the growth of murine Colon 38 cancer and interferes with the cytotoxic effect of fluorouracil in vitro

ea0014p171 | (1)

Muscle mitochondrial function is impaired in patients with prior acromegaly

ea0014p172 | (1)

Diagnosis and treatment of the ACTH-secreting neuroendocrine pancreatic tumors

ea0014p173 | (1)

Novel mutations in genes encoding succinate dehydrogenase complex subunits B (SDHB) and von Hippel-Lindau protein (VHL) in patients with nonsyndromic pheochromocytoma

ea0014p174 | (1)

Evaluation of plasma and urinary metanephrines as well as serum chromogranin A for the diagnosis of pheochromocytoma

ea0014p175 | (1)

¹¹C-5-hydroxytryptophan PET scan in diagnosis of ectopic Cushing’s syndrome from typical lung carcinoid: a case report

ea0014p176 | (1)

Mutational analysis in patients with nonsyndromic MEN1

ea0014p177 | (1)

Screening for mutations in exon 10, 11, 13 and 14 of the RET protooncogene associated with inherited medullary thiroid carcinoma (MTC) in Serbian population

ea0014p178 | (1)

The use of ¹⁸F-FDG PET/CT with or without rhTSH stimulation during follow-up of patients with differentiated thyroid carcinoma

ea0014p180 | (1)

Lower catch-up growth under rGH therapy at pre-pubertal pituitary dwarves diagnosed at an older age

ea0014p181 | (1)

The growth hormone – insulin-like growth factor-I axis in adult thalassemic patients

ea0014p182 | (1)

The role of BMP-3B in the establishment of zona glomerulosa in the adrenal gland

ea0014p183 | (1)

Selenium supply modulates growth spurt of selenoprotein P knockout mice

ea0014p184 | (1)

Factors affecting height velocity (HV) during GnRH analog therapy in girls with central precocious puberty (CPP)

ea0014p185 | (1)

Auxological and IGF system parameters in African in comparison with western countries normal children

ea0014p186 | (1)

X-linked neuronal T₃ transport defect: Allan Herndon Dudley syndrome

ea0014p187 | (1)

Cephalometric analysis and dental maturation in patients with Turner’s syndrome (TS)

ea0014p188 | (1)

Craniofacial development and dental maturation in growth hormone(GH)-deficient patients

ea0014p189 | (1)

Developing brain as an endocrine gland secreting GnRH and dopamine to general circulation

ea0014p190 | (1)

Closure by iptakalim, a cardiovascular K(ATP) channel opener, of rat islet beta-cell K(ATP) channels and its molecular basis

ea0014p191 | (1)

Plasma adiponectin and leptin levels in obese and insulin resistant postmenopausal females with type 2 diabetes

ea0014p192 | (1)

Pioglitazone modifies the effects of growth hormone on lipolysis and insulin sensitivity

ea0014p193 | (1)

The metabolic syndrome and associated sexual dysfunction: psychobiological correlates

ea0014p194 | (1)

A comparison of NCEP-ATP-III and IDF metabolic syndrome definitions with relation to metabolic syndrome associated sexual dysfunction

ea0014p195 | (1)

Effect of supervised structured exercise program for 16 weeks on metabolic, pulmonary and cardiovascular parameters in obese adolescents

ea0014p196 | (1)

Continuous administration of dihydrotestosterone or letrozole to immature female rats results in polycystic ovary syndrome characteristics at adult age

ea0014p197 | (1)

Neonatal sex steroid exposure of female rats results in insulin resistance and enlarged mesenteric adipocytes

ea0014p198 | (1)

Evaluation of visceral protein malnutrition in morbid obese patients operated on laparoscopic gastric bypass

ea0014p199 | (1)

Overconsumption of salty and sweet foods increases blood pressure in children

ea0014p200 | (1)

Expression of PKA regulatory subunits inversely correlates with BMI and insulin resistance parameters in human adipocytes from lean and obese subjects

ea0014p201 | (1)

Insulin resistance and fasting leptin’s relationship in subjects with metabolic syndrome

ea0014p202 | (1)

Epicardial adipose tissue, hepatic steatosis and obesity

ea0014p203 | (1)

Decreased 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys

ea0014p204 | (1)

Clinical presentation of nonclassic congenital adrenal hyperplasia &br;(NC-CAH): from suspicion to diagnosis

ea0014p205 | (1)

Daily and nightly urinary free cortisol ratio as a marker of the hypothalamic-pituitary-adrenal (HPA) axis activity in abdominal obesity

ea0014p206 | (1)

Interaction of hypothalamic receptors involved in weight regulation

ea0014p207 | (1)

Association of estrogen receptor-alpha gene polymorphisms with cerebrovascular disease in patients with metabolic syndrome

ea0014p208 | (1)

Bone mineral density and body composition in pubescent obese children endangered by metabolic syndrome

ea0014p209 | (1)

Influence of gaining weight on metabolic syndrome in the menopause

ea0014p210 | (1)

Effects of physiological bell-shaped elevations of free fatty acids on glucose metabolism and insulin sensitivity in humans

ea0014p211 | (1)

The metabolic changes induced by glucocorticoids: involvement of AMP-activated protein kinase

ea0014p212 | (1)

Net endogenous acid production and circulating leptin are associated with potentially bioactive free glucocorticoids in healthy lean women

ea0014p213 | (1)

Serum gamma-glutamiltransferase increases in type 2 diabetes mellitus but it is not related with the body mass index

ea0014p214 | (1)

Effects of pharmacological stimulation or blockade of cannabinoid receptor type 1 (CB1) on gene expression in mouse cultured adipocyte cells

ea0014p215 | (1)

Absence of TSH-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing rhTSH testing

ea0014p216 | (1)

Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome

ea0014p217 | (1)

Relationship between serum adiponectin and oxidative and non-oxidative glucose metabolism in apparently healthy humans

ea0014p218 | (1)

Relationships between serum adiponectin, interleukin 10 and interleukin 18 concentrations and muscle lipid fractions in healthy humans

ea0014p219 | (1)

Prevalence of metabolic syndrome in old men and its relation to ghrelin

ea0014p220 | (1)

Antipsychotic drugs and associated metabolic disorders

ea0014p221 | (1)

Associations between thyroid function parameters and adipokines in euthyroid individuals

ea0014p222 | (1)

Human adipose tissue derived DPP-IV regulates lipolysis through NPY in cultured abdominal subcutaneous adipocytes

ea0014p223 | (1)

The role of nitric oxide in pathogenesis of development of arterial hypertension during obesity

ea0014p224 | (1)

Effects of PGC-1α on endothelial function and apoptosis

ea0014p225 | (1)

Changes in serum glucose metabolism and growth hormone, cortisol, prolactin, ghrelin, leptin concentrations in normal weight patients with schizophrenia before treatment with atypical antipsychotics

ea0014p226 | (1)

Frequency of hypogonadism in males with type 2 diabetes and its relation with erectile dysfunction and obesity

ea0014p227 | (1)

Acute phase reactants and soluble cell adhesion molecules are associated to plasma leptin levels in obese nondiabetic children

ea0014p228 | (1)

Relationship between homocysteine level and low-grade systemic inflammation in obese children with metabolic syndrome

ea0014p229 | (1)

Oxidative stress and antioxidant defense is associated with adiposity in men among the urban population of south Iran

ea0014p230 | (1)

Ghrelin basal levels in metabolic syndrome

ea0014p231 | (1)

Pioglitazone treatment significantly decreases 5-alpha reductase activity and improves metabolic risk factors in PCOS

ea0014p232 | (1)

Plasma adiponectin and leptin levels in menopausal metabolic syndrome

ea0014p233 | (1)

Serum interleukin 6 and soluble form of interleukin 6 receptor concentrations in obese subjects with impaired glucose tolerance

ea0014p234 | (1)

Association of sex hormone-binding globulin (shbg) levels with measures of adiposity and metabolic profile in apparently healthy individuals

ea0014p235 | (1)

Comparative analysis of adiponectin, leptin and C-peptide levels in obese non-diabetic, type 1 diabetic and lean non-diabetic children

ea0014p236 | (1)

Effects of pioglitazone and metformin on body weight and the insulin resistance parameters in young patients with obesity

ea0014p237 | (1)

Plasma visfatin levels during oral glucose tolerance test in obese women

ea0014p238 | (1)

The association of high sensitivity C-reactive protein levels with body fat mass and body fat distribution

ea0014p239 | (1)

Innervation of white and brown adipose tissue: dual viral transneuronal tracing study

ea0014p240 | (1)

Identification of orexin receptors in brown adipocytes: functional effects of orexin-B

ea0014p241 | (1)

Waist circumference and BMI as predictors of arterial hypertension in childhood and adolescence in Latvia

ea0014p242 | (1)

Uric acid is an important predictor of metabolic disturbances in obese women

ea0014p243 | (1)

Fasting and postprandial plasma obestatin levels are reduced in obesity

ea0014p244 | (1)

Insulin resistance and insulin secretion in morbidly obese patients before and six months after bariatric surgery

ea0014p245 | (1)

Growth hormone Reduces Inflammation in Postmenopausal Women with Abdominal Obesity: a 12-month randomized placebo-controlled trial

ea0014p246 | (1)

Hyperactivity of the hypothalamic-pituitary-axis and adrenal hyperandrogenism in polycystic ovary syndrome: a consequence of 5 β-reductase hyperfunction

ea0014p247 | (1)

An examination of the prevalence of IDF and ATPIII defined metabolic syndrome: towards population based screening

ea0014p248 | (1)

Neuroendocrine and genetic aspects of metabolic disturbances in women with simple obesity, polycystic ovary syndrome (PCOS) and eating disorders

ea0014p249 | (1)

The effect of body composition and iron status on insulin resistance in hemodialysis patients

ea0014p250 | (1)

Relationship between obesity, insulin resistance and adipokines in morbidly obese women

ea0014p251 | (1)

Obesity in pre-school children –new epidemic problem?

ea0014p252 | (1)

Somatostatin receptor subtype 2 inhibits glucagon secretion and regulates glucose homeostasis

ea0014p253 | (1)

The role of combined treatment of arterial hypertension in patients with obesity

ea0014p254 | (1)

A registry of GDM in portugal

ea0014p255 | (1)

The effects of glucocorticoids on the expression of gluconeogenic and lipogenic enzymes in a rodent model of Cushing’s syndrome

ea0014p256 | (1)

HRT in treatment of dislipidemia in women with hypogonadotropic hypogonadism

ea0014p257 | (1)

Rare polimorphism in the intron of human Agouti- related protein gene is associated with obesity

ea0014p258 | (1)

The relationship between plasma androgens (testosterone and dehydroepiandrosterone sulfate), insulin resistance and visceral obesity in elderly men

ea0014p259 | (1)

Prevalence of metabolic syndrome in a cohort of young Mediterranean women with polycystic ovary syndrome and association with clinical and biochemical parameters

ea0014p260 | (1)

Obesity: diffusion weighted imaging features of brain

ea0014p261 | (1)

Hepatic and brain metabolism in young adults with glycogen storage disease type 1

ea0014p262 | (1)

Body composition and GH status in morbidly obese females before and after laparoscopic silicone adjustable-gastric banding

ea0014p263 | (1)

The importance of (TAAAA)n polymorphism of SHBG gene in the metabolic syndrome

ea0014p264 | (1)

Exophthalmos and its relation to adipokines in obese men

ea0014p265 | (1)

Influence of orlistat on adiponectin levels in obese women

ea0014p266 | (1)

Effect of omega-3 fatty acids on plasma adiponectin levels in Metabolic syndrome subjects

ea0014p267 | (1)

The polymorphism of PPAR and susceptibility to atherosclerosis in children with low birth weight (below 2500 g)

ea0014p268 | (1)

Visfatin, adiponectin, leptin and insulin sensitivity in severe obese women with normal and impaired glucose tolerance

ea0014p269 | (1)

Characterization of the rat homologue of the human neuroendocrine marker secretagogin – new functional implications by in vitro studies

ea0014p270 | (1)

Tilapia GnRH receptors: signal transduction and internalization rate

ea0014p271 | (1)

The relationship between carotid intima-media thickness metabolic and anthropometric parameters in healthy subjects

ea0014p272 | (1)

CRF and the Urocortins activate NFAT and induce catecholamine production in PC12 cells

ea0014p273 | (1)

Gs-dependent receptor endocytosis of melanocortin-4 receptors

ea0014p274 | (1)

The endocrine disruptor DDT appears to be an uncompetitive inverse agonist for activating TSHr mutants, FSH receptor and LH receptor

ea0014p275 | (1)

Effect of vitamin D replacement on endothelial function and oxidative stress in vitamin D deficient subjects

ea0014p276 | (1)

Transthyretin is up-regulated by androgens in mice liver and choroid plexus

ea0014p277 | (1)

Adrenal incidentalomas: aberrant expression of hormone receptors (preliminary results)

ea0014p278 | (1)

SMP30 is expressed in rat mammary gland and down-regulated by estradiol

ea0014p279 | (1)

Family mutation of PRKRA1A associated with Cushing syndrome from pigmented micronodular adrenal dysplasia

ea0014p280 | (1)

Non-genomic glucocorticoid effects on insulin secretion

ea0014p281 | (1)

The androgen receptor in the rat choroid plexus

ea0014p282 | (1)

Correlation of BclI, N363S and the ER22/23EK polymorphisms of the glucocorticoid receptor gene and bone mineral density in patients with endogenous and exogenous hypercortisolism

ea0014p283 | (1)

In vitro effects of 17 βE₂ and raloxifene on desmoid tumour derived cells

ea0014p284 | (1)

ESR2 genotypes are associated with a reduced relative risk for sporadic colorectal cancer

ea0014p285 | (1)

Frequency of three major glucocorticoid receptor gene polymorphisms in patients with adrenal incidentalomas

ea0014p286 | (1)

An analysis on delays in diagnosis of papillary thyroid cancer

ea0014p287 | (1)

Post-treatment effects of maternal hypothyroidism and thyroxin therapy on the subiculum neuronal density of the newborn rats

ea0014p288 | (1)

Abstract unavailable

ea0014p289 | (1)

The effects of subclinical hypothyroidism and replacement therapy on paraoxonase-1 (PON-1) and common carotis intima media thickness

ea0014p290 | (1)

Elevated plasma FABP4 (aP2) levels in hypothyroidism: potential implication for accelerated atherosclerosis

ea0014p291 | (1)

Markers of REDOX system at autoimmune diseases of thyroid gland

ea0014p292 | (1)

Selenium and its relation to thyroid antibodies, volume and ultrasound texture

ea0014p293 | (1)

Which prognosis criteria for thyroid anaplastic carcinoma?

ea0014p294 | (1)

Clinical-epidemiological characteristics of thyroid cancer (TC) in the Crimea

ea0014p295 | (1)

Fine needle aspiration biopsy of the thyroid. Cytohistologic correlation: experience in a central military hospital

ea0014p296 | (1)

Thyroid nodules in the elderly: role of ultrasound (US) and ultrasound-guided fine-needle aspiration biopsy (US-FNAB)

ea0014p297 | (1)

Clinical and pathological characteristics of thyroid anaplastic carcinoma: a regional survey in Auvergne

ea0014p298 | (1)

Abstract unavailable

ea0014p299 | (1)

Serum n-terminal pro-b-type natriuretic peptide (NT-proBNP) levels in patients with hyper- and hypothyroidism. Hyperthyroidism may affect NT-proBNP levels as independent of cardiac dysfunction

ea0014p300 | (1)

Soluble intercellular adhesion molecule-1(sICAM-1) levels and different schemes of Graves’ ophthalmopathy (GO) treatment

ea0014p301 | (1)

The influence of smoking upon the incidence of Graves’ disease and severity of Graves’ ophthalmopathy

ea0014p302 | (1)

Fewer and fewer thyroidectomies in the treatment of Graves’ disease

ea0014p303 | (1)

The prevalence of thyroid cancer in Albania

ea0014p304 | (1)

The prevalence of anti-C1q antibodies is increased in autoimmune thyroid disorders

ea0014p305 | (1)

The analgesic efficacy of lidocaine/prilocaine (EMLA) cream during the fine-needle aspiration biopsy of thyroid nodules

ea0014p306 | (1)

Radioactive iodine in the treatment of type 2 amiodarone-induced thyrotoxicosis

ea0014p307 | (1)

The prevalence of hyperprolactinaemia in overt and subclinical hypothyroidism

ea0014p308 | (1)

The role of parathyroid hormone monitoring after total thyroidectomy in predicting post-thyroidectomy related hypocalcaemia

ea0014p309 | (1)

Abstract unavailable

ea0014p310 | (1)

Intraorbital tissues effects of rituximab (RTX) treatment in patients with thyroid-associated ophthalmopathy (TAO)

ea0014p311 | (1)

Thyroid and gastric autoimmune diseases

ea0014p312 | (1)

VEGF, FGF and HGF in differentiated thyroid cancer

ea0014p313 | (1)

Fas and FasL expression on peripheral lymphocytes in patients with autoimmune thyroid disease

ea0014p314 | (1)

A novel pro-migratory action of TGFb in papillary carcinoma

ea0014p315 | (1)

Significance of accurate serum thyroglobulin cut-off values in the postoperative follow-up of differentiated thyroid carcinoma

ea0014p316 | (1)

Thyroid ultrasonography and ultrasonography-guided fine-needle aspiration biopsy of thyroid nodules in correlation with pathological findings

ea0014p317 | (1)

Different prevalence of type 1 and type 2 amiodarone-induced thyrotoxicosis over a 30-year period

ea0014p318 | (1)

Carbamazepine and risk of hypothyroidism: a prospective study

ea0014p319 | (1)

Epidemiology of thyroid cancer in the north eastern region of Poland

ea0014p320 | (1)

The Na⁺/I⁻ symporter (NIS) transports two of its substrates, I⁻ and ClO₄⁻, with different stoichiometries

ea0014p321 | (1)

Estimation of influence radioiodine treatment on course of Graves’ ophthalmopathy

ea0014p322 | (1)

Influence of a subclinical thyrotoxicosis on heart in various age-grades

ea0014p323 | (1)

Thyroid abnormalities during treatment with PEGIFNα-2a and PEGIFNα-2b in patients affected by HCV-related chronic disease: &br;a prospective randomized study

ea0014p324 | (1)

The effect of L-thyroxin theraphy on left ventricular diastolic dysfunction in patients with subclinical hypothyroidism

ea0014p325 | (1)

Risk factors for thyrotoxic cardiomyopathy

ea0014p326 | (1)

Partial withdrawal of levothyroxine to stimulate serum thyroglobulin (TG) in the follow-up of differentiated thyroid carcinoma (DTC)

ea0014p327 | (1)

Selected markers of endothelial dysfunction in patients with subclinical and overt hyperthyroidism

ea0014p328 | (1)

The changes in the incidence of nodular goitre, thyroid cancer and urine excretion of iodine in the inhabitants of north eastern Poland in 1997 and 2005

ea0014p329 | (1)

The role of deiodinases in thyronamine biosynthesis

ea0014p330 | (1)

Thyroid disease prevalance in Cushing’s disease

ea0014p331 | (1)

From sampling to analytics: experience and diagnostic consequences with some thyroid markers

ea0014p332 | (1)

G_q/11-dependent signaling of the tyhrotropin receptor regulates metallothionein 1 expression in human thyroid carcinoma cells

ea0014p333 | (1)

Association of cytokine gene polymorphism with Graves’ disease in Turkish population

ea0014p334 | (1)

Hashimoto’s encephalitis: role of diagnostic SPECT

ea0014p335 | (1)

Usefulness of Ki-67, PCNA, c-erbB-2 and CK 19 in the diagnosis of some thyroid follicular tumors

ea0014p336 | (1)

Soluble CTLA-4 is increased in Graves’ disease and not related to thyroid status or ophthalmopathy severity

ea0014p337 | (1)

The relationship of epicardial fat thickness with carotid intima media thickness and endothelial function in subclinical and overt hypothyroidism

ea0014p338 | (1)

Prevalence of thyroid antibodies in gestational diabetes mellitus

ea0014p339 | (1)

Thyroid investigation profile in patients with Hashimoto’s thyroiditis associated with other autoimmune disorders

ea0014p340 | (1)

Ultrasound patterns in patients with autoimmune thyroiditis

ea0014p341 | (1)

Iodine intake in Portugal: preliminary results in pregnant women

ea0014p342 | (1)

“False negative” results of Tg in patients with DTC (differentiated thyroid carcinoma)

ea0014p343 | (1)

The incidence of Hashimoto’s thyroiditis in the differentiated thyroid carcinoma

ea0014p344 | (1)

Thyroid cancer radioidine therapy using recombinant human TSH

ea0014p345 | (1)

Characterization of facilitative glucose transporters (GLUT) in human thyroid carcinoma cell lines

ea0014p346 | (1)

Genotype/phenotype relation for toxic thyroid nodules with or without TSH receptor mutations

ea0014p347 | (1)

High prevalence of ER22/23EK polymorphism of the glucocorticoid receptor gene in patients with Graves’ orbitopathy

ea0014p348 | (1)

Removal of tick box for TFT in pathology request forms reduces TFT performed during acute medical admission

ea0014p349 | (1)

Thyroid hormones in serum and cerebrospinal fluid in patients with brain tumor and acute stroke

ea0014p350 | (1)

The influence of universal salt-iodization on the iodine status of County Mures, detected through TSH determinations in newborns between 2001–2006

ea0014p351 | (1)

The evolution of hypothyroidism in pregnant women in County Mures between 2001–2006

ea0014p352 | (1)

The use of perchlorates in the treatment of some special forms of hyperthyroidism (report of two cases)

ea0014p353 | (1)

Iodine deficiency detected through urinary iodine excretion in school-children living in goiter prevalent regions of County Mures (2005–2006)

ea0014p354 | (1)

Endothelial function and hemostasis factors in hypothyroidism and subclinical hyperthyroidism

ea0014p355 | (1)

The relevance of thyroid echography in diagnostic of subclinical autoimmune thyroiditis during pregnancy and postpartum

ea0014p356 | (1)

Outcomes of a fixed dose of 370 MBq of radioiodine in hyperthyroidism

ea0014p357 | (1)

The lymphocyte interactions in thyroid tissue in graves’ disease

ea0014p358 | (1)

Water purification technology reduces iodine content of drinking water and contributes to iodine deficiency

ea0014p359 | (1)

The ultrastructural changes of thyroid tissue in recipient of bone marrow graft with Graves’ disease

ea0014p360 | (1)

Do patients and clinicians agree about which aspects of quality of life are relevant when evaluating the impact of thyroid diseases?

ea0014p361 | (1)

ret/PTC oncogene expression in papillary thyroid carcinoma

ea0014p362 | (1)

Prognostic value of polymorphisms and somatic RET proto-oncogene mutations in sporadic medullary thyroid carcinoma (MTC)

ea0014p363 | (1)

Partial redifferentiation of thyroid carcinoma cell lines treated with decitabine and retinoic acid

ea0014p364 | (1)

Comparison between serum calcitonin (CT) levels following Pentagastrin (Pg) and Calcium (CA) stimulus

ea0014p365 | (1)

Usefulness of calcitonin (CT) measurement in wash-out fluid from fine needle aspiration biopsy in thyroid nodules of patients with dectectable serum CT

ea0014p366 | (1)

Prognostic significance of BRAF mutation in patients affected by papillary thyroid carcinoma with a follow up of 20 years

ea0014p367 | (1)

Expression of folate receptor is down-regulated in somatotropinomas

ea0014p368 | (1)

Initiating mutations of BRAF gene in papillary thyroid carcinoma and their relation to gene expression profile

ea0014p369 | (1)

CRABP2 expression is up-regulated in parathyroid adenomas in correlation with HRPT2 down-regulation

ea0014p370 | (1)

Hypothyroid Graves’ ophthalmopathy: a case report

ea0014p371 | (1)

Increased risk of cardiovascular events in subclinical hyperthyroidism

ea0014p372 | (1)

Predictive factors for thyroid function abnormalities in patients with chronic hepatitis C treated with pegylated interferon and ribavirin

ea0014p373 | (1)

Aetiology and therapeutic guideines in thyrid dysfunction at the patients with chronic hepatitis C treated with pegylated interferon and ribavirin

ea0014p374 | (1)

Thyroid function in pregnancy

ea0014p375 | (1)

Painful Hashimoto’s thyroiditis – 2 cases report

ea0014p376 | (1)

Increase of L-thyroxine requirement during pregnancy

ea0014p377 | (1)

Safety of pharmacological treatment of thyroid diseases &br;during pregnancy

ea0014p378 | (1)

Fine-needle aspiration biopsy – possibilities and limitations

ea0014p379 | (1)

Association of p53 codon 72 polymorphism with thyroid cancer

ea0014p380 | (1)

Adiponectin in patients with Graves’ ophthalmopathy (GO)

ea0014p381 | (1)

Resistin levels in hypothyroid patients before and after treatment &br;with thyroxin

ea0014p382 | (1)

Increased need for oral thyroxine in total thyroidectomized patients: a prospective analysis

ea0014p383 | (1)

Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients

ea0014p384 | (1)

The effect of nodule size on diagnostic efficacy in fine needle aspiration biopsy of thyroid nodules

ea0014p385 | (1)

The effect of thyroxine suppression therapy on the diagnostic efficacy of fine needle aspiration biopsy in thyroid nodules

ea0014p386 | (1)

Congenital hypothyroidism – results of a protocol implemented &br;1993–2006

ea0014p387 | (1)

Relationship of treated maternal hyperthyroidism &br;and perinatal outcome

ea0014p388 | (1)

Characteristics of locally advanced differentiated thyroid cancer in &br;a cohort of patients surgically treated at one oncological institution

ea0014p389 | (1)

Abnormal calcium metabolism as shown by the Ellsworth-Howard test and its relation to pseudohypoparathyroidism II

ea0014p390 | (1)

The role of non-calcemic analogs of vitamin D in differentiation of cultured rat bone marrow into osteoblast-like cells: age and sex differences

ea0014p391 | (1)

Mutual modulation of the vitamin D system and estrogen receptors in human bone cells in culture

ea0014p392 | (1)

Less-calcemic vitamin D analogs enhance biological responses and modulate responsiveness to gonadal steroids in skeletal tissues

ea0014p393 | (1)

The predictive role of body mass and composition upon bone mineral content: differences between premenopausal and postmenopausal women

ea0014p394 | (1)

Increased cortisol level in type 1 diabetic patient may lead decreasing of bone mineral density

ea0014p395 | (1)

Body fat concentration is a poor predictor of bone mineral content in hyperthyroid women

ea0014p396 | (1)

Vitamin D receptor gene polymorphisms: influence on bone metabolism in type 1 diabetic patients

ea0014p397 | (1)

Change in bone mass due to hyperthyroidism

ea0014p398 | (1)

Correlation between bone minerale density and bone turnover in delayed puberty

ea0014p399 | (1)

Prevalence of primary hyperparatiroidism in treated and untreated breast cancer

ea0014p400 | (1)

Relationship between antropometric and metabolic parameters and parathyroid hormone levels in women

ea0014p401 | (1)

Serum calcium levels and metabolic disturbances in obese women

ea0014p402 | (1)

Marginal periodontal pathology in patients with pituitary disorders

ea0014p403 | (1)

Tumor induced osteomalacia caused by haemangioma of the acetabular surface

ea0014p404 | (1)

Fracture risk in diabetic patients

ea0014p405 | (1)

Predictors of bone mineral density in women with primary hyperparathyroidism

ea0014p406 | (1)

Carotid intima media thickness and bone turnover in type 2 diabetic patients

ea0014p407 | (1)

Primary hyperparathyroidism is associated with an increased risk of vertebral fracture assessed by morphometric x-ray absorptiometry

ea0014p409 | (1)

Bone mineral density and bone markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid carcinoma

ea0014p410 | (1)

Bone mineral density in end-stage chronic kidney disease patients

ea0014p411 | (1)

Vitamin D receptor gene Bsm1 and Fok1 polymorphisms and indices of bone mass and bone turnover in healty young Turkish men and women

ea0014p412 | (1)

Parathyroid sonography in patients with normocalcemic primary hyperparathyroidism

ea0014p413 | (1)

Diagnostic role of GNAS1 mutation screening in patients with pseudohypoparathyroidism

ea0014p414 | (1)

CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulphate level and bone mineral density in postmenopausal women

ea0014p415 | (1)

Evaluation of diastolic function and its relationship with carotis intima media thickness and endothelial function in asymtomatic hyperparathyroid patients

ea0014p416 | (1)

Cinacalcet (Mimpara®, Amgen) is more effective than bisphosphonates at controlling hypercalcemia in patients with parathyroid carcinoma: a case study

ea0014p417 | (1)

Is there any relationship between the BsmI polymorphism in the vitamin D receptor gene and the occurrence of glucocorticoid-induced osteoporosis in asthmatic patients with long-term glucocorticoid treatment?

ea0014p418 | (1)

The relationship between the increased body mass index and the bone fracture prevalence in postmenopausal pollen allergic women

ea0014p419 | (1)

Decreased bone resorption in H1 histamine receptor antagonist treated allergic children

ea0014p420 | (1)

Changes of bone metabolism at the onset of puberty

ea0014p421 | (1)

Hypophosphatemic rickets and mutations in the PHEX gene

ea0014p422 | (1)

Changes of serum bone marker concentrations after effective therapy of patients with Cushing’s syndrome

ea0014p423 | (1)

Percutaneous ethanol injection therapy in patients with primary and secondary hyperparathyroidism

ea0014p424 | (1)

Juvenile osteoporosis in untreated GH-deficient patient – is treatment with GH replacement indicated? A clinical case report

ea0014p425 | (1)

Biomarkers of hypercoagulability and inflammation in primary hyperparathyroidism

ea0014p426 | (1)

Dehydroepiandrosterone and bone mineral density in elderly women

ea0014p427 | (1)

Bone mineral density and calcium deficiencies in adult patients with celiac disease

ea0014p428 | (1)

Implication of magnesium in calcium metabolism – a case report

ea0014p429 | (1)

Implication of magnesium in calcium metabolism – a case report

ea0014p430 | (1)

The effect of surgical cure of acromegaly on glycemic control in an elderly female patient suffering from type 2 diabetes – a case report

ea0014p431 | (1)

Endocrine function in a 48,XXYY adult

ea0014p432 | (1)

Simultaneous occurrence of multicentric medullary and papillary thyroid cancer: a case report

ea0014p433 | (1)

Simultaneous bilateral transperitoneal laparoscopic adrenalectomy (SBTLA)

ea0014p434 | (1)

Amyloid goitre: report of a case

ea0014p435 | (1)

Autoimmune polyglandular syndrome type I associated with motor focal epilepsy – a case report

ea0014p436 | (1)

Postpartum autoimmune hypophysitis, autoimmune hyperthyroidism and reversible hepatitis at a patient with partial empty sella

ea0014p437 | (1)

One case of sellar and suprasellar chordoma

ea0014p438 | (1)

Cutaneous modifications suggestive for Cushing’s syndrome induced by topical corticoid application

ea0014p439 | (1)

Clinical presentation of a patient with giant prolactinoma

ea0014p440 | (1)

Thyrotropin-producing pituitary adenoma discovered because of galactorrhea

ea0014p441 | (1)

An 8-year-old boy with seizures and hypokalemia due to a paraganglioma

ea0014p442 | (1)

Neuropsychiatric manifestations in patients of primary hyperparathyroidism and outcome following surgery

ea0014p443 | (1)

Hyperthyroidism in molar pregnancy: rapid preoperative preparation by plasmapheresis and complete after evacuation

ea0014p444 | (1)

Finasteride treatment of premature androgenetic alopecia

ea0014p445 | (1)

Secondary adrenal failure and secondary amenorrhea due to hydromorphone treatment

ea0014p446 | (1)

Pseudophaeochromocytoma in Parkinson’s disease

ea0014p447 | (1)

Kallmann syndrome – deletion of the short arm of chromosome 8

ea0014p448 | (1)

Hyperprolactinemia in post-acute phase after severe TBI or SAH is mostly iatrogenic or due to physical stress

ea0014p449 | (1)

Rapid normalization of highly elevated serum chromogranin A after cessation of proton pump inhibitor therapy

ea0014p450 | (1)

Case of primary bilateral adrenal lymphoma

ea0014p451 | (1)

Familial hypocalciuric hypercalcemia: mutation in the calcium sensing receptor gene

ea0014p452 | (1)

Structured assessment of neuroendocrine dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage – the interdisciplinary German database

ea0014p453 | (1)

Normal age-dependent values of serum insulin growth factor (IGF)–I: results from a healthy Italian population

ea0014p454 | (1)

Four cases of propylthiouracil–induced antineutrophil cytoplasmatic antibody-associated autoimmune syndrome

ea0014p455 | (1)

Difficult management of a thyrotoxic patient with abnormal liver function tests

ea0014p456 | (1)

Dermatological manifestations of the neuroendocrine cancer: a four cases report of primitive and metastatic Merkerl cell tumor

ea0014p457 | (1)

Retrospective analysis of diagnostic and treatment outcomes of primary aldosteronism

ea0014p458 | (1)

A case with hypercalcemia caused by hyperparathyroidism and multiple myeloma

ea0014p459 | (1)

Prostate specific antigen (PSA) in women with menstrual disturbances and mastopathy

ea0014p460 | (1)

Selected parameters of lipid metabolism in patients with Turner’s syndrome

ea0014p461 | (1)

Successive gestational hyperandrogenism with maternal virilization and female pseudohermaphroditism

ea0014p462 | (1)

Tetraploid/diploid mosaicism: case report of a 35-year-old woman

ea0014p463 | (1)

Genotype-phenotype correlation in Romanian patients with classical forms of 21-hydroxylase deficiency

ea0014p464 | (1)

Cushing’s syndrome in paediatric age – casuistic, evolution of investigation tests and treatment options in our institution throughout the last 20 years

ea0014p465 | (1)

Thyroidectomy as the last chance treatment for life threatening thyrotoxicosis: a case report

ea0014p466 | (1)

Insulinoma and gastrinoma in MEN 1: case report

ea0014p467 | (1)

Multiple endocrine dependent tumours in a dog patient without measurable endocrine consequences

ea0014p468 | (1)

Case report: Adrenal glands and stress: hypercortisolism in the course of urosepsis

ea0014p469 | (1)

Long-term experience and pharmacogenetic aspects of safety in 101 treatment-years with a long-acting formulation of testosterone undecanoate in substitution therapy of 66 hypogonadal men

ea0014p470 | (1)

Thyrotoxic hypokalemic periodic paralysis in two Caucasian females

ea0014p471 | (1)

Pseudophaeochrocytoma presenting with catatonia - a novel observation

ea0014p472 | (1)

Relapse of hyperthyroidism in Graves’ disease after long-term drug treatment

ea0014p473 | (1)

Bloch-sulzberger syndrome, hypothyroidism and a pituitary incidentaloma: a case report

ea0014p474 | (1)

Extreme obesity as an important obstacle in diagnosing a patient with MEN1

ea0014p475 | (1)

Six months physiological DHEA substitution in female adrenal failure: impact on quality of life and sexual parameters.

ea0014p476 | (1)

Central hypothyrodism and dyslipidemia induced by bexarotene in patients with cutaneous T-cell lymphoma

ea0014p477 | (1)

Thyroid dysplasia – 30 cases of lingual thyroids

ea0014p478 | (1)

Primary hyperparathyroidism during pregnancy – case report

ea0014p479 | (1)

Pituitary insufficiency after traumatic brain injury in southwest Hungary

ea0014p480 | (1)

Bartter syndrome – a case of secondary hyperaldosteronism

ea0014p481 | (1)

A Wellbeing patch induced Adrenal crisis

ea0014p482 | (1)

Antidepressants and elevated catecholamines

ea0014p483 | (1)

Myasthenia gravis and autoimmune Addison’s disease in a patient with thymoma

ea0014p484 | (1)

Severe hyperandrogenism during the entire course of pregnancy does not cause virilization of a female infant born

ea0014p485 | (1)

Regression of metastatic gastric carcinoid associated with atrophic gastritis and after octreotid treatment

ea0014p486 | (1)

Persistent fever after surgical removal of a craniopharyngioma: diagnosis pitfalls and therapeutic difficulties

ea0014p487 | (1)

Study of aldosterone secretion in patients with essential hypertension using a modified suppression test

ea0014p488 | (1)

Study of aldosterone secretion in patients with essential hypertension using a modified suppression test

ea0014p489 | (1)

GH-secreting adenomas may disappear with long-acting somatostatin analoque (octreotide-LAR) treatment

ea0014p490 | (1)

Adrenal rest tumours in 11-β hydroxylase deficiency

ea0014p491 | (1)

The possible role of genetics in severity of thyrotoxicosis

ea0014p492 | (1)

The challenge of managing thionamide induced agranulocytosis in a patient with Graves’ disease

ea0014p493 | (1)

Five-year treatment experience with metformin in polycystic ovary syndrome

ea0014p494 | (1)

Hand-Foot-Uterus syndrome in a patient with secondary amenorrhea: a rare case

ea0014p495 | (1)

Neonatal ventricular septal defect and late diagnosis of Turner syndrome

ea0014p496 | (1)

Interleukin-6-producing pheochromocytoma presenting with fever of unknown origin

ea0014p497 | (1)

Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene

ea0014p498 | (1)

A case of paraganglioma of glomus caroticum with lung metastasis

ea0014p499 | (1)

Intracranial giant sarcoma in an acromegalic patient after radiotherapy

ea0014p500 | (1)

Short stature and neurofibromatosis type 1 – issues of diagnosis

ea0014p501 | (1)

Paraneoplastic Cushing’s syndrome presenting as psychosis – case report

ea0014p502 | (1)

Endocrine tumour registry – tools for endocrine epidemiology

ea0014p503 | (1)

Tumour induced osteomalacia – a phosphaturic mesenchymal tumour

ea0014p504 | (1)

Unusual onset of Graves’ disease – case report

ea0014p505 | (1)

Growth hormone replacement therapy and metabolic parameters in adult-onset GH-deficiency: long-term effects.

ea0014p506 | (1)

Conventional glucocorticoid replacement therapy in patients with Addison’s disease: effects on metabolic and bone parameters

ea0014p507 | (1)

Gastric electrical stimulation in patients with severe diabetes mellitus associated gastroparesis – a cost benefit analysis

ea0014p508 | (1)

Levels of serum and salivary cortisol during low dose ACTH test in young adult-onset diabetes mellitus Type 1 patients

ea0014p509 | (1)

Long-term pegvisomant treatment in acromegaly

ea0014p510 | (1)

The assesment of life quality satisfaction in women with Turner’s syndrome

ea0014p511 | (1)

Pheochromocytoma in pediatric age

ea0014p512 | (1)

Ectopic localization of the pituitary bright spot in a patient with idiopathic central diabetes inspidus

ea0014p513 | (1)

Diabetes insipidus due to pituitary metastasis of breast cancer

ea0014p514 | (1)

Multicystic dysplastic kidney – a potential accelerant of complications in type I diabetes mellitus

ea0014p515 | (1)

MEN-1 phenotype without detectible MEN-1 mutation

ea0014p516 | (1)

Composite medullary and papillary tumor with mixed lymph node metastases

ea0014p517 | (1)

Management of endocrine syndrome in a patient with plurihormonal neuroendocrine tumour

ea0014p518 | (1)

Brown tumor in hyperparathyroidism – clinical case

ea0014p519 | (1)

Investigation of early atherosclerotic changes in acromegalic patients

ea0014p520 | (1)

Food preference, central serotoninergic activity, depression and insulin resistance in obese and lean healthy men: a pilot study

ea0014p521 | (1)

Somatic, body composition and psychological particularities in a group of untreated adult pituitary dwarves

ea0014p522 | (1)

L-thyroid hormone enhancement of antidepressant treatment in major depressive episode

ea0014p523 | (1)

Evaluation of cognitive functions by using P300 auditory event related potentials (ERPs) in amateur kickboxers: a preliminary study

ea0014p524 | (1)

Changes in hypothalamo-pituitary-testicular axis sensitivity in aging male

ea0014p525 | (1)

Glutamatergic neurons and synaptic contacts between glutamatergic axon terminals and chemically identified nerve cells in the rat hypothalamic suprachiasmatic nucleus

ea0014p526 | (1)

Laterality in the supraspinal innervation of the adrenal gland: a dual-virus tracer study

ea0014p527 | (1)

Prolonged orocecal transit time and small intestinal bacterial overgrowth in acromegalic patients

ea0014p528 | (1)

Adulthood follow-up of a large number of patients with congenital morphological alteration of anterior and/or posterior pituitary lobes

ea0014p529 | (1)

Non-NMDA glutamate receptor antagonist injected into the mesencephalic dorsal raphe nucleus inhibits the suckling-induced prolactin release and administered into the lateral cerebral ventricle interferes with the diurnal fluctuations of plasma prolactin of male rats

ea0014p530 | (1)

The expression of the neuroprotective factor seladin-1 is up-regulated by thyroid hormones in human neuronal precursor cells, but not in mature neurons

ea0014p531 | (1)

Long-term evaluation of hypotalamic-pituitary-adrenal (HPA) axis in acromegalic patients during somatostatin analogs therapy and after successful surgery

ea0014p532 | (1)

Growth hormone deficiency and recombinant hGH (rhGH) replacement in children with idiopathic isolated GH deficiency: effects on the hypothalamus-pituitary-adrenal axis

ea0014p533 | (1)

Effects of glucocorticoid replacement on bone mass in women after long-term remission of Cushing’s syndrome

ea0014p534 | (1)

Factors influencing the rhythmic secretion of melatonin in human

ea0014p535 | (1)

Neurotropic profiles of androgens - mechanisms and targets

ea0014p536 | (1)

Age-related changes of circadian rhythmicity: relationship with melatonin.

ea0014p537 | (1)

Idiopathic isolated GH deficiency (IGHD) and combined pituitary hormone deficiency (CPHD) in Italy: genetic screening and clinical correlates

ea0014p538 | (1)

Increased intraovarian levels of noradrenaline and NGF precede the follicular changes in the rat ovary at the end of reproductive period

ea0014p539 | (1)

Incorporation and release of ³H-norepinephrine by granulosa cells: Novel functionality for endocrine cells

ea0014p540 | (1)

Treatment of Cushing’s disease by transsphenoidal pituitary microsurgery: prognosis factors and long-term follow-up

ea0014p541 | (1)

Ketoconazole before transsphenoidal surgery in Cushing’s disease patiens as a good alternative to glucocorticoids perioperatory treatment

ea0014p542 | (1)

Analysis of three different tests in the diagnosis of growth hormone deficit (GHD) in patients with severe cerebral trauma

ea0014p543 | (1)

Meningiomas in patients diagnosed with acromegaly: the report of two cases

ea0014p544 | (1)

Topoisomerase II alpha expression in pituitary tumours – preliminary results

ea0014p545 | (1)

Is there an endocrine explanation for persistent neuropsychological disabilities long after traumatic brain injury (TBI)?

ea0014p546 | (1)

ACTH and cortisol responses to ghrelin and DDAVP in patients with Cushing’s disease (CD)

ea0014p547 | (1)

Effect of treatment with somatostatin analogue on glucose homeostasis in patients with acromegaly

ea0014p548 | (1)

Effects of combined treatment with cabergoline and somatostatin analogues (SAA) on GH and IGF-I levels and tumor volume in patients with acromegaly not fully responsive to SAA

ea0014p549 | (1)

Macroprolactin: the clinically and diagnostically importance

ea0014p550 | (1)

OASIS: observational study on the international clinical practice for the treatment of recently diagnosed acromegalic patients

ea0014p551 | (1)

Comparison of basal ghrelin and leptin serum levels and after an oral glucose tolerance test in active and inactive acromegalic patients

ea0014p552 | (1)

Determinants of the acromegalic cardiomyopathy: a prospective, controlled study in 205 patients

ea0014p553 | (1)

Growing incidence of idiopathic isolated secondary adrenal insufficiency.

ea0014p554 | (1)

The role of fibrinogen and CRP in cardiovascular risk in patients with acromegaly

ea0014p555 | (1)

Evaluation of insulin sensitivity with euglycemic hyperinsulinemic clamp technique in non-obese patients with microprolactinoma

ea0014p556 | (1)

Evaluation of insulin sensitivity with euglycemic hyperinsulinemic clamp technique in non-obese patients with microprolactinoma

ea0014p557 | (1)

Comparative analysis of reactivity of macroprolactin in first and second-generation prolactin assays

ea0014p558 | (1)

Cabergoline treatment in Cushing’s disease: effect on hypertension, glucose intolerance and dyslipidemia.

ea0014p559 | (1)

Development and validation of a questionnaire to evaluate health-related quality of life in patients with Cushing’s syndrome

ea0014p560 | (1)

Differential expression of genes related to aggressiveness in non-functioning pituitary adenomas

ea0014p561 | (1)

Effects of CST-8, a synthetic cortistatin analogue, in humans

ea0014p562 | (1)

Prevalence of anterior pituitary dysfunction in patients following traumatic brain injury (TBI) in a German multi-centre screening program

ea0014p563 | (1)

Distribution of type 1 cannabinoid receptor (CB1) immunoreactive axons in the mouse hypothalamus

ea0014p564 | (1)

Immunohistochemistry of pure growth hormone-containing and mixed growth hormone/prolactin-containing pituitary adenomas

ea0014p565 | (1)

The effects of pasireotide (SOM230) on glucose metabolism and growth hormone (GH) nadir during oral glucose tolerance test (OGTT) in 12 patients with acromegaly from a Phase II study

ea0014p566 | (1)

Cerebrospinal fluid (CSF)/serum albumin ratio shows no alteration of the blood-brain barrier in patients with pituitary adenomas and high CSF levels of pituitary hormones

ea0014p567 | (1)

Medial cerebral artery occlusion 25 years after cranial radiation therapy in acromegaly

ea0014p568 | (1)

The hypothalamic-pituitary-adrenal axis in premenopausal females with psoriatic arthritis

ea0014p569 | (1)

Cortisol and dexamethasone exert different negative feedback action in humans

ea0014p570 | (1)

The role of vasopressin in the hypothalamo-pituitary-adrenal axis regulation during the perinatal period: paradoxical corticosterone elevation without an ACTH rise

ea0014p571 | (1)

Riluzole treatment does not affect growth hormone (GH) secretion in amyotrophic lateral sclerosis

ea0014p572 | (1)

Impairment of GH secretion by ghrelin stimulation test in primary hyperparathyroidism (PHP)

ea0014p573 | (1)

The influence of cabergoline treatment on seminal fluid

ea0014p574 | (1)

Fractionated stereotactic conformal radiotherapy for skull base benign tumours: an endocrinological follow-up

ea0014p575 | (1)

The GH releasing activity of ghrelin is insensitive to the negative growth hormone (GH) autofeedback in humans

ea0014p576 | (1)

Impaired GH secretion in women with HIV-related lipodystrophy

ea0014p577 | (1)

Midnight salivary cortisol vs. urinary free cortisol for the diagnosis of Cushing’s syndrome

ea0014p578 | (1)

Behavioural and biological effects of des-Gln14-ghrelin

ea0014p579 | (1)

Diagnostic accuracy of bilateral inferior petrosal sinus sampling performed following a combined stimulation with CRH and desmopressin

ea0014p580 | (1)

The empty sella syndrome – particularities of the clinical features depending on etiology

ea0014p581 | (1)

Effects of successful transsphenoidal surgery on cardiovascular function in elderly acromegalics

ea0014p582 | (1)

Clinicopathologic correlation in cases with macronodular hyperplasia

ea0014p583 | (1)

The endocrine and behavioural actions of neuromedine S

ea0014p584 | (1)

Acute and long-term pituitary insufficiency in traumatic brain injury: a prospective cohort study

ea0014p585 | (1)

Genetic analysis of PROP1 gene in patients with childhood-onset combined pituitary hormone deficiency (CPHD)

ea0014p586 | (1)

The role of G-protein- and β-arrestin dependent signaling mechanisms in the tonic regulation of prolactin secretion

ea0014p587 | (1)

Secondary hypothalamic amenorrhea as the initial manifestation of HIV infection

ea0014p588 | (1)

Hypopituitary patients have an increased prevalence of cardiovascular risk factors

ea0014p589 | (1)

The evaluation of ghrelin concentration in patients treated for acromegaly and of ghrelin expression in pituitary somatotropinomas

ea0014p590 | (1)

Ghrelin, inhibits AMPK (AMP-dependent protein kinase), a regulator of cell proliferation and metabolism

ea0014p591 | (1)

Self-concept in patients with PCOS

ea0014p592 | (1)

Evaluation of hypotalamic-pituitary-gonadal (HPG) axis and GH-IGF-I axis in adult patients with celiac disease

ea0014p593 | (1)

The effects of salsolinol on the peripheral sympathetic activity of hypophysectomized, adrenalectomized and medullectomized rats

ea0014p594 | (1)

Cardiovascular risk and hypopituitarism: evaluation of the global cardiovascular absolute risk, using the individual score of the Progetto CUORE of the Istituto Superiore della Sanità

ea0014p595 | (1)

Traumatic brain injury (TBI) and lipid profile abnormalities: study 12 months after the brain injury

ea0014p596 | (1)

Traumatic brain injury (TBI) and lipid profile abnormalities: study 12 months after the brain injury

ea0014p597 | (1)

Does concealment of bad news stimulate the HPA or the SAS axis?

ea0014p598 | (1)

Non-dopaminergic neurons expressing individual enzymes of dopamine synthesis in the arcuate nucleus: development and functional significance

ea0014p599 | (1)

Impact of somatostatin analogs on the heart in acromegaly: a meta-analysis

ea0014p600 | (1)

Thyrotropinoma response to somatostatin receptor ligand (SRL) – key feature in preoperative treatment

ea0014p601 | (1)

Glucose resistance in acromegaly is reversible during somatostatin analogues treatment

ea0014p602 | (1)

Endocrine and neuro-ophtalmologic correlates of primary empty sella

ea0014p603 | (1)

Growth hormone deficiency in patients with acromegaly after ‘successful’ transsphenoidal surgery

ea0014p604 | (1)

Excess mortality in women with pituitary disease: results of a meta-analysis

ea0014p605 | (1)

Familial acromegaly – the role of the AIP gene

ea0014p606 | (1)

Validation of different insulin sensitivity indices in GH deficiency children using roc curve analysis

ea0014p607 | (1)

The transition phase in GHD patients and metabolic alterations: life span variations of insulin sensitivity?

ea0014p608 | (1)

Growth hormone deficiency in succesfully treated acromegalic patients is not protective from cardiac complications

ea0014p609 | (1)

Implications for molecular mechanisms of glycoprotein hormone receptors using a new sequence-structure-function analysis resource

ea0014p610 | (1)

A comparison between the efficacy and safety of pegvisomant to that of octreotide LAR in patients with acromegaly

ea0014p611 | (1)

Androtest: a structured interview for the screening of hypogonadism in patients with sexual dysfunction

ea0014p612 | (1)

Assessment of the relational factor in male patients consulting for sexual dysfunction: the concept of couple sexual dysfunction

ea0014p613 | (1)

Effect of hormone replacement therapy apart from growth hormone on the endothelial functions in patients with Sheehan’s syndrome

ea0014p614 | (1)

Family history of diabetes mellitus determines insulin sensitivity and beta cell dysfunction in polycystic ovary syndrome

ea0014p615 | (1)

Retinol-binding protein-4 in polycystic ovary synrome - relationship with obesity and androgen levels

ea0014p616 | (1)

Protein metabolism in a model of premature ovarian failure, Turner syndrome, and the impact of hormone replacement therapy

ea0014p617 | (1)

Differences in the onset of puberty in selected inbred mouse strains

ea0014p618 | (1)

The investigation of hypothalamo-pituitary-gonadal axis in patients with epilepsy

ea0014p619 | (1)

Varicocele sclerotherapy improves serum inhibin B levels and seminal parameters

ea0014p620 | (1)

LH receptor gene expression and splicing variants in marmoset (Callithrix jacchus) testis and adrenal gland at puberty

ea0014p621 | (1)

Protamine 1 and Protamine 2 sequence variants in teratozoospermia

ea0014p622 | (1)

Ghrelin effects on spontaneous and stimulated LH secretion in human males

ea0014p623 | (1)

Differential effects of two-week treatment with atorvastatin or elocalcitol, two RhoA/ROK signalling modulators, on erectile function and sildenafil responsiveness in spontaneously hypertensive rats

ea0014p624 | (1)

Testosterone regulates RhoA/Rho-kinase signalling in two distinct animal models of chemical diabetes

ea0014p625 | (1)

Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat

ea0014p626 | (1)

Androgenicity, androgen receptor polymorphism and pharmacogenetics

ea0014p627 | (1)

Characterization and functional role of an androgen-dependent PDE5 activity in bladder

ea0014p628 | (1)

Testosterone levels correlate positively with HDL cholesterol levels in men with Type 2 diabetes

ea0014p629 | (1)

Mutations of GnRH receptor and GPR54 in a cohort of patients with idiopathic hypogonadotropic hypogonadism

ea0014p630 | (1)

Assessment of non-enzymatic antioxidant profile of women on contraceptives

ea0014p631 | (1)

Hypothalamic-pituitary-gonadal axis responses of the male rats short and long time static magnetic fields (50 Hz) exposure

ea0014p632 | (1)

Adrenal rest tissue in gonads in 70 French patients with classical congenital adrenal hyperplasia (21 hydroxylase deficiency)

ea0014p633 | (1)

Three months exercise training improves cardiopulmonary functional capacity in polycystic ovary syndrome

ea0014p634 | (1)

Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in polycystic ovary syndrome

ea0014p635 | (1)

Age at menarche in relation to adult obesity

ea0014p636 | (1)

The multi-PDZ domain protein MUPP1: a scaffolding protein controlling the acrosome reaction in mammalian spermatozoa

ea0014p637 | (1)

Expression of the G-protein α-subunit gustducin in mammalian spermatozoa

ea0014p638 | (1)

Delayed puberty with extreme uterine hypotrophy: do not conclude too early to the absence of the uterus

ea0014p639 | (1)

Screening and treatment of gestational diabetes and impaired glucose tolerance in Georgia

ea0014p640 | (1)

The effects of cycloheximide, actinomycine D and indomethacin on progesterone release stimulated by PACAP 38 from cultured rat ovarian granulosa cells

ea0014p641 | (1)

XX-male syndrome: clinical, hormonal and molecular genetic findings in comparison to Klinefelter patients and normal men

ea0014p642 | (1)

Expansion of CD4⁺CD25⁺ regulatory T cells during murine pregnancy is not driven by pregnancy-associated hormones

ea0014p643 | (1)

The clinical outcomes of stimulation of ovulation in patients with idiopathic hypogonadotropic hypogonadism (IHH) caused by mutations of GnRH receptor

ea0014p644 | (1)

Atherogenic indexes in women with premature ovarian failure-POF

ea0014p645 | (1)

Effect of age and testosterone on sleep related erections

ea0014p646 | (1)

Hormonal and seminal parameters in patients with testicular neoplasia or lymphoproliferative disorders: two year follow up

ea0014p647 | (1)

Immunohistochemical evaluation of ghrelin expression in polycystic ovaries in patients with PCOS.

ea0014p648 | (1)

Ovarian hyperstimulation syndrome during IVF induction revealing a gonadotroph adenoma

ea0014p649 | (1)

Insulin levels and lipid profile in lean women with polycystic ovary syndrome

ea0014p650 | (1)

Demonstration of estrogen receptor–β in human gonadotropin-releasing hormone neurons

ea0014p651 | (1)

Asymmetric dimethylarginine levels and carotid intima media thickness in patients with polycystic ovary syndrome

ea0014p652 | (1)

Ghrelin levels in obese patients with polycistic ovary syndrome

ea0014p653 | (1)

Ghrelin levels in lean patients with polycistic ovary syndrome

ea0014p654 | (1)

Adrenal morphology on CT-scan in patients with congenital adrenal hyperplasia

ea0014p655 | (1)

Anti-oxidant activity of seminal plasma in fertile and infertile men

ea0014p656 | (1)

Reproductive health of women born to bromocriptine-treated mothers

ea0014p657 | (1)

The difference in the level of lipids, CRP, androgens and prolactins between PCOS women with metabolic syndrome and PCOS women without metabolic syndrome

ea0014p658 | (1)

The difference in the level of lipids, CRP, androgens and prolactins between PCOS women with metabolic syndrome and PCOS women without metabolic syndrome

ea0014p659 | (1)

The difference in the level of lipids, CRP, androgens and prolactins between PCOS women with metabolic syndrome and PCOS women without metabolic syndrome

ea0014p660 | (1)

The difference in the level of lipids, CRP, androgens and prolactins between PCOS women with metabolic syndrome and PCOS women without metabolic syndrome

ea0014p661 | (1)

Expression of p63 and Notch system in the rat testis and vaso-epididymal system during postnatal development

ea0014p662 | (1)

Transcripts expressed in the mouse testis during sex-determining period

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Biosci Abstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more